Concepedia

Publication | Open Access

Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration

DOIFull Paper Access

171

Citations

21

References

2020

Year

Arshad M. Khanani, Sunil Patel, Philip J. Ferrone, Aaron Osborne, Jayashree Sahni, Susanna M. Grzeschik, Karen Basu, Jason S. Ehrlich, Zdenka Hašková, Pravin U. Dugel
JAMA Ophthalmology

Abstract

ClinicalTrials.gov Identifier: NCT03038880.

References

YearCitations

Page 1